Thomas J. Herzfeld Advisors »

Crispr Therapeutics shares owned by Thomas J. Herzfeld Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Thomas J. Herzfeld Advisors from 13F filings

Historical chart of Thomas J. Herzfeld Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Thomas J. Herzfeld Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Thomas J. Herzfeld Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $28k 625 45.39
2023-06-30 $35k 625 56.14
2023-03-31 $28k 625 45.23
2022-12-31 $25k 625 40.65
2022-09-30 $41k 625 65.60
2022-06-30 $38k 625 60.80
2022-03-31 $39k 625 62.40
2021-12-31 $30k 400 75.00
2021-09-30 $45k 400 112.50
2021-06-30 $67k 415 161.45
2021-03-31 $51k 417 122.30
2020-12-31 $3.0k 17 176.47
2020-09-30 $2.0k 17 117.65